Previous 10 | Next 10 |
Imago BioSciences (NASDAQ:IMGO): Q3 GAAP EPS of -$0.44 misses by $0.08. Press Release. For further details see: Imago BioSciences EPS misses by $0.08
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc . (“Imago”) (Nasdaq: IMGO), a clinical-stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today reported financial results...
Imago BioSciences, Inc . (Imago) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced two abstracts have been accepted for oral presentation at the 63 rd American Society of...
Imago BioSciences , Inc. (Imago) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today announced that it will be added to the Russell® 2000 Index as part of the planned secon...
Imago BioSciences Inc. (NASDAQ:IMGO) traded today at a new 52-week high of $35.68. This new high was reached on approximately average trading volume as 121,000 shares traded hands, while the average 30-day volume is approximately 95,000 shares. Imago BioSciences Inc is a clinical-stage b...
Imago BioSciences, Inc . (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasms (MPNs), today reported financial results for the second quarter ended June 30, 2021 and highlighted...
You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
Imago BioSciences Inc. (NASDAQ:IMGO) traded at a new 52-week high today of $26.00. So far today approximately 121,000 shares have been exchanged, as compared to an average 30-day volume of 137,000 shares. Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and...
Imago BioSciences Inc. (NASDAQ:IMGO) traded at a new 52-week high today of $20.06. Approximately 121,000 shares have changed hands today, as compared to an average 30-day volume of 131,000 shares. Imago BioSciences Inc. (NASDAQ:IMGO) defies analysts with a current price ($18.81) 11.6% ab...
News, Short Squeeze, Breakout and More Instantly...
Imago BioSciences Inc. Company Name:
IMGO Stock Symbol:
NASDAQ Market:
Imago BioSciences Inc. Website:
NEW YORK, NY / ACCESSWIRE / December 27, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Imago BioSciences, Inc. (NASDAQ: IMG...
NEW YORK, NY / ACCESSWIRE / December 23, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Lakeland Bancorp, Inc. (NASDAQ:LBAI)...